German pharmacies battle closures and online competition as owners adapt with social media and new services
German pharmacies face closures and online competition; owners use Instagram, extra services and cannabis sales while pushing for higher fees and reforms.
German pharmacies are increasingly using social media, new services and diversified sales to stay afloat as closures and pressure from online rivals reshape the market. Two pharmacists in North Rhine-Westphalia and Hesse—one who turned his golden retriever into an Instagram mascot and another who opened a sanitätshaus and a care network—illustrate how local owners are adapting while awaiting promised reimbursement reforms. The shifts come amid falling pharmacy numbers, rising online revenue and growing disputes over billing and retaxations.
A canine ambassador draws customers into a small-town pharmacy
Paula, a snow-white golden retriever in a white lab coat, has become the public face of the Barbara Apotheke in Kamen and helped attract a steady stream of visitors. Owner Dennis Nigge and a videographer friend post short Instagram clips showing Paula behind the counter and in routine pharmacy roles, and the account has drawn tens of thousands of followers. The social media presence generates goodwill, occasional sponsorships and interest from potential employees, even if it does not replace core revenues.
Paula’s videos are deliberately lighthearted but careful: Nigge says they avoid violating Germany’s Heilmittelwerbegesetz while explaining basic health topics to viewers. For many customers, stopping by to see the dog is the primary reason to visit, a sign that local engagement can still create foot traffic for brick-and-mortar pharmacies.
Decline in numbers and the rise of online giants
The backdrop for these local experiments is a stark drop in the sector: the Bundesvereinigung Deutscher Apothekerverbände reports a 12 percent fall in pharmacy numbers between 2022 and 2025. By the end of March 2026 there were about 16,541 pharmacies nationwide, and many owners say revenue mixes are shifting unfavorably. While average net turnover for a pharmacy remains in the millions, online players such as Shop Apotheke and Doc Morris have recorded rapid growth and far higher online sales.
Consulting figures show online market leaders dramatically increasing their German revenues in recent years, intensifying price and distribution competition. The e‑prescription rollout has also made it easier for customers to choose mail-order pharmacies, amplifying the threat to local dispensaries.
Cross-border rules and discount practices complicate competition
Price competition is further complicated by EU rules that subject online pharmacies to the laws of their host country, creating regulatory disparities. Many major online vendors operate from the Netherlands, where discounting over-the-counter products is more permissive and VAT on non-prescription medicine is lower than in Germany. That regulatory gap allows some platforms to offer incentives that on-site pharmacies cannot legally match, leaving local owners at a structural disadvantage.
Although German law requires equal prices for prescription drugs for statutory-insured patients, online players can still use promotions on other items and profit from lower operating costs. Owners say the uneven playing field is one of the clearest drivers of market consolidation.
Reimbursement fights and cash-flow pressure
Apothecaries also face steady administrative and financial burdens: fixed dispensing fees, late reimbursements and retaxations erode margins and complicate cash flow. Pharmacies have campaigned for an increase in the fixed fee per dispensed pack from €8.35 to €9.50, a change referenced in the coalition agreement but not yet implemented. Meanwhile, retaxations—penalties applied by health insurers when prescriptions are deemed faulty—can force pharmacies to absorb full costs or pursue lengthy appeals.
Owners describe repeated delays in reimbursement and frequent disputes over how much of a partly used pack should be paid by insurers when used for a recipe-based preparation. The result, they say, is a resource-intensive struggle with payers that distracts from patient care and threatens smaller operations’ viability.
Diversification into services, supplies and cannabis
Faced with these pressures, some pharmacists are expanding services and product lines. In Erzhausen, Nojan Nejatian opened a sanitätshaus next to his Heegbach Apotheke, launched a supplement brand and built a local care network to generate revenue and deepen community ties. The sanitätshaus reportedly contributes a significant share of gross profit, while the care network connects medical and social services and runs public education events.
Other pharmacies are selling medical cannabis as a new income source, with owners stressing pharmaceutical oversight and strict patient screening. Government plans to restrict postal distribution of medical cannabis could advantage local dispensaries, and some pharmacists expect expanded in‑pharmacy services—such as vaccinations, blood draws and chronic‑care consultations—to become more important revenue streams if reimbursement rules follow.
Workload, reform expectations and the road ahead
Pharmacists welcome proposals to expand pharmaceutical services but warn that time and staffing requirements must be matched by fair compensation. Practical examples underline the imbalance: a routine blood pressure check can take 15–30 minutes while netting little more than a modest fee, owners say, and preparing individualized prescriptions often yields minimal extra pay. Many hope the government’s apothekenreform and planned negotiations between the GKV-Spitzenverband and the Deutsche Apothekerverband will deliver a durable increase in fees and clearer rules.
Until reforms materialize, local pharmacies are balancing patient care, entrepreneurial initiatives and public advocacy to survive. Community ties, niche services and creative outreach can mitigate some commercial pressures, but owners warn that unless compensation and regulatory fairness improve, more closures will follow.
Local pharmacists insist they will not abandon the profession despite the headwinds, arguing that pharmacy work is also a health mission rather than pure market logic. Their immediate task is practical: maintain services for patients, manage cash flow and press policymakers to enact the promised reforms that many say are essential for the future of German pharmacies.
